← Singular Venture
SINGULAR VENTURE
Kevin Wilson · Principal · New York
Private Placement · Pre-IPO Access

Neuralink.

The brain is the next interface.
Invest in Neuralink through a Singular Venture SPV — before any public-market listing.
$9.65B
Last priced round
Jun 2025
26
People implanted
Four countries
Zero
Public shares
In existence
SINGULAR VENTURE
KEVIN WILSON · PRINCIPAL · NEW YORK
KEVIN@SINGULARVENTURE.COM
An SPV is a group buying in together. Singular Venture forms the SPV, the SPV buys the Neuralink shares, and you hold a membership interest in the SPV — plus your pro-rata share of any gain, after fees.
SINGULAR VENTURE
Kevin Wilson · Principal · New York
SINGULAR VENTURE
KEVIN WILSON · PRINCIPAL · NEW YORK
02 / 13
An SPV is a group buying in together. Singular Venture forms the SPV, the SPV buys the Neuralink shares, and you hold a membership interest in the SPV — plus your pro-rata share of any gain, after fees.
SINGULAR VENTURE
Kevin Wilson · Principal · New York
01 · The Proof

Functional use in 26 implanted participants.

Investigational device · results preliminary
131221 26 JAN 24JAN 25SEP 25JAN 26 JUN 26
10 hrs
A day of use, first patient
4
Countries running trials
2
FDA Breakthrough tags
SINGULAR VENTURE
KEVIN WILSON · PRINCIPAL · NEW YORK
03 / 13
An SPV is a group buying in together. Singular Venture forms the SPV, the SPV buys the Neuralink shares, and you hold a membership interest in the SPV — plus your pro-rata share of any gain, after fees.
SINGULAR VENTURE
Kevin Wilson · Principal · New York
02 · What It Is

One implant. Three senses.

A coin-sized chip reads the brain's own signals and turns thought into action. The same platform runs in reverse — writing signal into the cortex.
01

Telepathy

Control a computer by thinking — cursor, keyboard, robotic arm.

In humans since Jan 2024
02

Voice

Speech decoded from thought, for people who have lost the ability to speak.

In trials
03

Blindsight

Sight written directly into the visual cortex, bypassing the eye.

First human implant targeted 2026
SINGULAR VENTURE
KEVIN WILSON · PRINCIPAL · NEW YORK
04 / 13
An SPV is a group buying in together. Singular Venture forms the SPV, the SPV buys the Neuralink shares, and you hold a membership interest in the SPV — plus your pro-rata share of any gain, after fees.
SINGULAR VENTURE
Kevin Wilson · Principal · New York
03 · The Moat

Bandwidth is the moat.

NEURALINK N1 IMPLANT 1,024 ELECTRODES NEURACLE NEO · CHINA, MAR 2026 8 CONTACTS
The robot
A surgical robot no competitor has.R1 threads hair-thin electrodes into living tissue, now through the dura — Musk says the procedure goes near-fully automated in 2026.
Vertical
Chip, robot and decoding software, built as one company.Hardware and surgery improve on the same clock. That compounding is hard to copy.
SINGULAR VENTURE
KEVIN WILSON · PRINCIPAL · NEW YORK
05 / 13
An SPV is a group buying in together. Singular Venture forms the SPV, the SPV buys the Neuralink shares, and you hold a membership interest in the SPV — plus your pro-rata share of any gain, after fees.
SINGULAR VENTURE
Kevin Wilson · Principal · New York
04 · The Prize

Potential across serious neurological conditions.

01
Paralysis
In trials
02
Speech loss · ALS
In trials
03
Blindness
2026 target
04
Stroke, hearing, memory
Roadmap
$3.3B
BCI market, 2026
$13.9B
Forecast by 2035
17%
Forecast CAGR
SINGULAR VENTURE
KEVIN WILSON · PRINCIPAL · NEW YORK
06 / 13
An SPV is a group buying in together. Singular Venture forms the SPV, the SPV buys the Neuralink shares, and you hold a membership interest in the SPV — plus your pro-rata share of any gain, after fees.
SINGULAR VENTURE
Kevin Wilson · Principal · New York
05 · Momentum

The mark keeps stepping up.

$650M raised in the Series E, June 2025 · ~$1.3B total primary capital raised to date.
$3.5B
Nov 2023 · Series D
$9.65B
Jun 2025 · Series E, post-money
≈$40B
Jul 2026 · Secondary estimate
≈4.5×
Step from the last priced round
The $40B mark is an unverified secondary estimate implied by per-share quotes — not a company-priced round.
SINGULAR VENTURE
KEVIN WILSON · PRINCIPAL · NEW YORK
07 / 13
An SPV is a group buying in together. Singular Venture forms the SPV, the SPV buys the Neuralink shares, and you hold a membership interest in the SPV — plus your pro-rata share of any gain, after fees.
SINGULAR VENTURE
Kevin Wilson · Principal · New York
06 · By the Numbers

The company, in six figures.

$9.65B
Valuation, last priced round
26
Patients implanted to date
675
Employees, May 2026
1,024
Recording electrodes, N1
3
Studies — PRIME, VOICE, Blindsight
2016
Founded · Fremont & Austin
2026 plan
High-volume device production and near-fully automated surgery.Musk's stated plan for the year: manufacture at scale, take the surgeon out of the loop.
SINGULAR VENTURE
KEVIN WILSON · PRINCIPAL · NEW YORK
08 / 13
An SPV is a group buying in together. Singular Venture forms the SPV, the SPV buys the Neuralink shares, and you hold a membership interest in the SPV — plus your pro-rata share of any gain, after fees.
SINGULAR VENTURE
Kevin Wilson · Principal · New York
07 · The Cap Table

Who's already on the cap table.

Elon Musk
Founder · Every round
ARK Invest · Sequoia
Series E
Founders Fund · Thrive
Series E
Lightspeed · DFJ · Valor
Growth
Qatar Investment Authority
Sovereign
Six rounds. 27 investors. Musk has backed every one and owns the majority.
Investors listed have not endorsed this offering. Participation buys an interest in a Singular Venture SPV — the SPV holds the Neuralink shares, so your name does not appear on this cap table.
SINGULAR VENTURE
KEVIN WILSON · PRINCIPAL · NEW YORK
09 / 13
An SPV is a group buying in together. Singular Venture forms the SPV, the SPV buys the Neuralink shares, and you hold a membership interest in the SPV — plus your pro-rata share of any gain, after fees.
SINGULAR VENTURE
Kevin Wilson · Principal · New York
08 · Why Now

Still private — no announced IPO.

i

Private-market access is available now.

No IPO has been announced. Eligible investors may gain exposure to Neuralink through a private investment vehicle before any potential public listing.

ii

2026 is the scale year

High-volume production, automated surgery and the first Blindsight implant are all on this year's stated plan.

iii

Milestones move the price

$3.5B → $9.65B → secondary marks several times higher. Company milestones may affect private-market valuations, although no increase in value or liquidity event is assured.

SINGULAR VENTURE
KEVIN WILSON · PRINCIPAL · NEW YORK
10 / 13
An SPV is a group buying in together. Singular Venture forms the SPV, the SPV buys the Neuralink shares, and you hold a membership interest in the SPV — plus your pro-rata share of any gain, after fees.
SINGULAR VENTURE
Kevin Wilson · Principal · New York
09 · Risks

What every investor should weigh honestly.

01

Pre-revenue, pre-approval.Nothing is cleared for sale in the US. The trial record runs to 2031.

02

Real competition.Synchron, Precision and Paradromics are in humans — and China's first BCI is already cleared to sell.

03

Surgical and safety risk.Brain implants carry hard risks; the earliest device saw threads retract.

04

Illiquid and speculative.Private stock can't be freely sold. You may hold for years — or lose the entire investment.

Secondary valuations are reported estimates, not priced rounds. No liquidity event has been announced, and none is promised.
SINGULAR VENTURE
KEVIN WILSON · PRINCIPAL · NEW YORK
11 / 13
An SPV is a group buying in together. Singular Venture forms the SPV, the SPV buys the Neuralink shares, and you hold a membership interest in the SPV — plus your pro-rata share of any gain, after fees.
SINGULAR VENTURE
Check out your client concierge
2:14 AM▲ ▮
ASK SINGULAR
Where is my money?
It's in Prometheus Opportunity Fund I — $50,000, wired June 29, carried at cost.
Answered in 4 seconds
Ask anything
SINGULAR VENTUREThomas Larsen · Client
OverviewInvestmentsDocumentsStatementsMessages
Artificial Intelligence

Project

Position
Confirmed
Basis
AT COST
Status
CLOSED
ON CLOSEClosing ConfirmationOPEN
DAY ONESubscription AgreementOPEN
Live · updated with every close
01

Ask Singular

A 24/7 AI. Ask anything about your investment, any hour.

02

Client Portal

One login. Your position, every document, every update.

Anything the concierge can't answer, we call you right back.
kevin@singularventure.com
operations@singularventure.com
+1 (973) 229-2497

The deal closes.Your concierge opens.

Singular Venture forms the SPV, the SPV buys the Neuralink shares, and you hold a membership interest in the SPV. The concierge and portal do not replace the definitive offering documents.
SINGULAR VENTURE
KEVIN WILSON · PRINCIPAL · NEW YORK
12 / 13
SINGULAR VENTURE
Kevin Wilson · Principal · New York
How to participate

Invest in Neuralink through a Singular Venture SPV.

Eligible investors buy an interest in a Singular Venture SPV. The SPV purchases and holds the Neuralink shares. Three steps, start to finish.

Kevin Wilson
Kevin Wilson
Principal · Singular Venture
New York
kevin@singularventure.com operations@singularventure.com
+1 (973) 229-2497
STEP 01
Confirm accredited-investor status and reserve an allocation.
STEP 02
Review the definitive offering documents — structure, fees, transfer restrictions and risks.
STEP 03
Countersign and fund. You own an interest in the Singular Venture SPV; the SPV owns the Neuralink shares.
IMPORTANT INVESTMENT INFORMATION. Shares of Neuralink are purchased and held by a Singular Venture SPV — a limited liability company formed for this single investment. Investors become members of the SPV and hold a membership interest in it, sized to what they put in. The SPV is the shareholder of record on Neuralink's cap table; investors do not hold Neuralink shares in their own name and do not have shareholder rights in Neuralink. Investors share in the economic results of the SPV's investment, after fees and expenses. Eligibility requirements, transfer restrictions and conflicts of interest are described in the definitive offering documents, which control all terms. Private investments are speculative, illiquid and difficult to value; an exit typically takes years, none is guaranteed, and you may lose the entire investment. No IPO, acquisition, liquidity event or return is guaranteed. For informational purposes only; not an offer to sell or a solicitation to buy any security. Any offering is made solely to eligible accredited investors. Figures reflect publicly reported information about Neuralink and are not verified or endorsed by the company. Secondary valuations are third-party estimates, not priced rounds. Singular Venture is not affiliated with Neuralink, Tesla, SpaceX or xAI.
SINGULAR VENTURE
KEVIN WILSON · PRINCIPAL · NEW YORK
KEVIN@ · OPERATIONS@SINGULARVENTURE.COM